Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Low-doses of Naltrexone (LDN) on Pain Perception and Quality of Life in Women With Vulvodynia

NCT05955313 is registered in ClinicalTrials.gov with Medical University of Lublin as lead sponsor.

NCT NCT05955313
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05955313 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Low-doses of Naltrexone (LDN) on Pain Perception and Quality of Life in Women With Vulvodynia
Lead sponsor
Medical University of Lublin
Phase
Phase 2
Overall status
Recruiting
Start date
May 31, 2023
Completion date
December 31, 2026
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

naltrexone, quality of life, vulvodynia